Here Are The Year's Highest Priced Psychedelics Stocks In US Markets

After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.  

And now, after 2022's enormous success, we are holding our second Benzinga Psychedelics Capital Conference. Powered by our excellent Psychedelic Advisory Council, which includes many of the major figures in the space, the PCC will be a perfect place to get deals done, raise money and meet investors and key partners.  

To be held on April 13, following two days of the Benzinga Cannabis Capital Conference (April 11-12) at the Fontainebleau Miami Beach Hotel, Florida.

Among some of the outstanding speakers confirmed so far is among the top 10 publicly priced psychedelic companies, Enveric Biosciences CEO Joseph Tucker, who will talk about the next-generation psychedelics market. 

Meanwhile, let's look at the 10 highest trading psychedelics stocks over the past year, spanning March 3, 2022 to March 3, 2023. 

Some of the companies are still at the top of the list even after a year of stock price volatility, while others are among the largest players conducting the most advanced clinical trials to date.

The list follows the highest market cap to the lowest.

GH Research PLC GHRS: 

• $16.62 on 3/3/22 vs. $10.26 on 3/3/23 

• Highest: $19.87 (4/4/22) 

• Lowest: $8.77 (1/9/23) 

• Year range: $8.46 - $20.32 

• Current market cap: $533.73 million

COMPASS Pathways PLC CMPS: 

• $13.31 on 3/3/22 vs. $8.41 on 3/3/23 

• Highest: $20.07 (8/5/22) 

• Lowest: $7.06 on (5/12/22)

• Year range: $6.54 - $21.50 

• Current market cap: $360.93 million

Incannex Healthcare ADR IXHL: 

• $14.94 on 3/3/22 vs. $2.54 on 3/3/23  

• Highest achieved: $35.50 (3/15/22) 

• Lowest: $2.41 (2/27/23)

• Current market cap: $149.81 million

FSD Pharma Inc. HUGE: 

• $1.02 on 3/3/22 vs. $1.37 on 3/3/23 

• Highest: $1.81 (2/21/23) 

• Lowest: $0.73 (12/27/22) 

• Year range: $0.62 - $1.88 

• Current market cap: $52.9 million

Irwin Naturals Inc. IWINF:

• $2.87 on 3/3/22 vs. $2.80 on 3/2/23 

• Highest: $3.97 (7/13/22) 

• Lowest: $1.08 (9/26/22) 

• Year range: $0.80 - $3.97 

• Current market cap: $9.1 million

See also: These Are The 11 Biggest Psychedelics News And Trends You May Have Missed Last Year

Clearmind Medicine Inc. CMND: 

• $11.70 on 3/4/22 vs. $3.08 on 3/3/23 

• Highest: $17.10 (4/7/22) 

• Lowest: $1.50 (6/14/22)

• Year range: $1.50 - $17.10 

• Current market cap: $8.3 million

Silo Pharma Inc. SILO: 

• $9.02 on 3/4/22 vs. $2.26 on 3/3/23 

• Highest: $12.40 (4/8/22) 

• Lowest: $2.20 (2/27/23) 

• Year range: $2.15 - $12.45 

• Current market cap: $7.13 million

Enveric Biosciences Inc. ENVB: 

• $14.37 on 3/3/22 vs. $1.92 on 3/3/23

• Highest: $19.36 (3/23/22) 

• Lowest: $1.67 (12/28/22) 

• Year range: $1.57 - $20.00 

• Current market cap: $3.99 million 

Jaguar Health Inc. JAGX: 

• $31.07 on 3/3/22 vs. $1.57 on 3/3/23 

• Highest: $53.40 (4/4/22) 

• Lowest: $1.57 (3/3/23) 

• Year range: $1.53 - $61.13 

• Current market cap: $3.04 million

atai Life Sciences NV ATAI: 

• $5.56 on 3/3/22 vs. $1.55 on 3/3/23

• Highest: $5.65 (3/18/22) 

• Lowest: $1.55 (3/3/23) 

• Year range: $1.45 - $5.80 

• Current market cap: $1.12 million

Mind Medicine Inc. (MindMed) MNMD: 

• $16.65 on 3/3/22 vs. $3.56 on 3/3/23 

• Highest: $18.45 (3/22/22) 

• Lowest: $2.14 (12/28/22) 

• Year range: $2.12 - $19.95 

• Current market cap: UNAVAILABLE

• Join us at the Benzinga Psychedelics Capital Conference to meet and learn from the amazing people who are leading this new field. More company participants will be confirmed soon. Get your tickets now before prices go up. If you're interested in joining the outstanding list of speakers, send us a note.

Photo: Benzinga edit with photo by Shutterstock.